Detalhe da pesquisa
1.
Long-term results from a clinical study of xevinapant plus chemoradiotherapy in people with high-risk locally advanced squamous cell carcinoma of the head and neck: a plain language summary.
Future Oncol
; 19(26): 1769-1776, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439181
2.
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
Lancet Oncol
; 21(9): 1173-1187, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32758455
3.
Letter to the Editor: SMAC mimetics inhibit human T cell proliferation and fail to augment type 1 cytokine responses.
Cell Immunol
; 395-396: 104772, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996259
4.
Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.
Future Oncol
; 14(9): 877-889, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29578359
5.
An imbalance in competing mortality favouring Debio 1143 - Authors' reply.
Lancet Oncol
; 21(11): e503, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152295
6.
Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial.
Radiother Oncol
; 197: 110329, 2024 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768714
7.
Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial.
Eur J Cancer
; 183: 24-37, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796234
8.
Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary.
Cancers (Basel)
; 13(10)2021 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34067697
9.
Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial.
Radiother Oncol
; 150: 18-25, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32417348
10.
10-Year Locoregional Control with Postoperative External Beam Radiotherapy in Patients with Locally Advanced High-Risk Non-Anaplastic Thyroid Carcinoma De Novo or at Relapse, a Propensity Score Analysis.
Cancers (Basel)
; 11(6)2019 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31248183
11.
Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study.
Eur J Cancer
; 111: 69-81, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826659
12.
Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.
J Clin Oncol
; 36(31): 3077-3083, 2018 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30016178
13.
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.
J Clin Oncol
; : JCO2017762518, 2018 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29878867
14.
Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
Int J Radiat Oncol Biol Phys
; 99(3): 590-595, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29280453
15.
Subcutaneous interleukin-2 and interferon alfa administration in patients with metastatic renal cell carcinoma: final results of SCAPP III, a large, multicenter, phase II, nonrandomized study with sequential analysis design--the Subcutaneous Administration Propeukin Program Cooperative Group.
J Clin Oncol
; 21(21): 3987-94, 2003 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14581421
16.
A rationale for chemoradiation (vs radiotherapy) in salivary gland cancers? On behalf of the REFCOR (French rare head and neck cancer network).
Crit Rev Oncol Hematol
; 91(2): 142-58, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24636481
17.
The rare cancer network: ongoing studies and future strategy.
Rare Tumors
; 6(3): 5465, 2014 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25276326
18.
[Treatment of primary thyroid lymphomas]. / Traitement des lymphomes thyroïdiens primitifs de stade localisé
Bull Cancer
; 100(10): 1031-42, 2013 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-24077086
19.
Phase I/II and pharmacokinetic study of intravenous vinflunine in combination with cisplatin for the treatment of chemonaive patients with advanced non-small-cell lung cancer.
Clin Lung Cancer
; 11(2): 105-13, 2010 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20199976
20.
Cervical node of unknown primary: patterns of care and factors influencing the choice of clinical target volumes.
Oral Oncol
; 50(5): e25-6, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24630259